Bristol-Myers Squibb To Pay City $7.5M in Damages

This article is from the archive of The New York Sun before the launch of its new website in 2022. The Sun has neither altered nor updated such articles but will seek to correct any errors, mis-categorizations or other problems introduced during transfer.

The New York Sun

The pharmaceutical company Bristol-Myers Squibb agreed yesterday to pay New York City $7.5 million in damages stemming from allegations of Medicaid fraud.

The company also agreed to pay $40 million to New York State under the deal, which was negotiated by the city and by the state’s attorney general, Andrew Cuomo.

The agreement stems from claims made in 2004, when the city filed lawsuits against 44 pharmaceutical companies for allegedly inflating the average wholesale price of their drugs. As a result, the city alleged that millions of dollars of charges were added to its Medicaid budget.

The suits sought to “rein in the widespread fraudulent practices that unlawfully inflate the City’s Medicaid costs,” the city’s corporation counsel, Michael Cardozo, said in a statement announcing the settlement. “We are pleased at the successful resolution reached with one of the defendants, and hope to reach similarly successful resolutions with others.”


The New York Sun

© 2025 The New York Sun Company, LLC. All rights reserved.

Use of this site constitutes acceptance of our Terms of Use and Privacy Policy. The material on this site is protected by copyright law and may not be reproduced, distributed, transmitted, cached or otherwise used.

The New York Sun

Sign in or  Create a free account

or
By continuing you agree to our Privacy Policy and Terms of Use